Clinical Trial

Endoscopic Band Ligation for Type 2 Diabetes Mellitus (ENDOBAND-DM)

Study acronym: ENDOBAND-DM
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a pilot clinical study evaluating the safety and feasibility of Endoscopic Band Ligation (ENDOBAND-DM) applied to the second through fourth parts of the duodenum - from just distal to the ampulla of Vater to the ligament of Treitz - in patients with type 2 diabetes mellitus (T2DM). The goal is to induce mucosal remodeling in this duodenal segment, potentially enhancing gut hormone signaling and improving glycemic control. Participants will be monitored for changes in HbA1c, fasting glucose, and insulin sensitivity over 6-12 months.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-05.
Trial Details
NCT Number NCT07117721
Lead Sponsor El Katib Hospital
Conditions Type 2 Diabetes Mellitus (T2DM)
Enrollment 10 participants
Start Date 2026-01-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-15